Liz Burton, PhD

Mom | Research | Taco enthusiast | Executive Director @MDAndersonNews - Views are my own.

[Liz Burton, PhD @Liz_htx03]

Roda Amaria, @PAscierto, @ProfCUBlankNKI , @ProfGLongMIA, Alex Menzies, @ProfRAScolyer, @HTawbi_MD, Michael Tetzlaff, Alex van Akkooi, @JenWargoMD

[Liz Burton, PhD @Liz_htx03]

Honored & excited that the INMC is receiving the SITC 40th Anniversary Collaboration Award! Since
2016, this global effort has shaped melanoma care & sparked cross- cancer collaborations. Grateful to co lead w/ a tremendous team of leaders to make this shared vision possible!

[Society for Immunotherapy of Cancer @sitcancer]

Congratulations to Dr. Andres Salazar of @oncovir, along with the INMC, led by Dr. Elizabeth Burton of @MDAndersonNews, and the STAR Collaborative, led by Dr. Stephen Gottschalk of @StJude, recipients of 40th Anniversary Collaboration Awards. LEARN MORE: https://t.co/VQcfvkNGVe

[Hussein Tawbi, MD, PhD @HTawbi_MDPhD]

Excited to see this work now out in JCO, important and unique long term data for the newest checkpoint combination. B7-H3 result could be practice informing & importantly targetable. Congrats to @Liz_htx03 for the incredible work to make this happen & Profs. Amaria & @JenWargoMD

[Liz Burton, PhD @Liz_htx03]

What an honor to present some of my PhD work to amazing colleagues and friends at the Bridges meeting this week in Naples. Incredible group & brilliant scientists sharing insights and perspectives.

[Allison Betof, MD, PhD, FASCO @DrBetofMDPhD]

Comprehensive and exciting overview of neoadjuvant PD-1+LAG-3 data in melanoma, lung, and beyond. @Liz_htx03 has done extensive biomarker analyses and highlights some familiar (B cells, IFN) and some novel (TIGIT, B7-H3) markers. B7-H3 is quite novel and potentially targetable! #ImmunotherapyBridge2024

[Nature Medicine @NatureMedicine]

Out now for #ESMO24! In #ISPY2.2, neoadjuvant Dato-DXd, followed by sequential CT w/ or w/o targeted therapy & optional early resection after each therapy block in pts w/ high-risk #BreastCancer, was superior to SOC in a subgroup of pts. @DrLauraEsserman https://t.co/qjGsrx8Vbx

[Hussein Tawbi, MD, PhD @HTawbi_MDPhD]

The International Neoadjuvant Melanoma Consortium (#INMC) meets for the 8th year running, so much progress & still much to consider, kicked off by @Liz_htx03 providing context to multiple neoadjuvant trial results in melanoma & other cancers #ESMO24

[Allison Betof, MD, PhD, FASCO @DrBetofMDPhD]

Great start to #ESMO24 with the International Neoadjuvant Melanoma Consortium meeting. @Liz_htx03 kicks us off showing us the progress in our field since the first meeting in 2016.

[Liz Burton, PhD @Liz_htx03]

@BcellBruno @tonyrcillo @Vignali_Lab @UPMCHillmanCC @PittTweet Congrats Tullia and team!!

[Liz Burton, PhD @Liz_htx03]

2/2 So immensely grateful for the support of my committee, colleagues, family, and dear friends - flying in from San Francisco (@DrBetofMDPhD), @HTawbi_MD bringing churros and hosting an amazing celebration dinner - there are no words for how grateful I am for each of you.

[Liz Burton, PhD @Liz_htx03]

1/2 And PhD done! What a crazy couple of years. Big big thank you to my amazing supervising professor @ChrisRFrei , the TS PhD faculty, Dr Roda Amaria @MDAndersonNews and the support of my amazing international committee members @PAscierto and @ProfCUBlankNKI

[Neil D. Gross, MD, FACS @DrNeilGross]

Great idea to add for future meeting. Work led by @DrMCabanillas @MDAndersonNews adding #neoadjuvant #immunotherapy to BRAF targeted therapy has shown great promise in anaplastic #thyroid #cancer!

[Neil D. Gross, MD, FACS @DrNeilGross]

The beauty of Napoli only to be outdone by the incredible scientific discussions pushing the frontiers of #neoadjuvant #immunotherapy across #Cancer at INNOVATE, hands down the best meeting of 2024 led by @Liz_htx03 @PAscierto @ProfCUBlankNKI!

[Liz Burton, PhD @Liz_htx03]

(2/2) Representation from multiple disciplines in academia, ESMO & SITC presidents (@curijoey & @EmensLeisha), and pharma. Much progress made, and much more to come. Many thanks to our speakers & session chairs, for their expertise, participation, and leadership!

[Liz Burton, PhD @Liz_htx03]

(1/2) What a humbling opportunity to organize and co-chair the first Intl Neoadjuvant Immunotherapy Across Cancers (INNOVATE) mtg in Naples with @PAscierto & @ProfCUBlankNKI bringing together critical leaders for 2 days of deep discussion.

[Liz Burton, PhD @Liz_htx03]

@MyriamChalabi @NKI_nl @lab_kok @ProfCUBlankNKI @HaanenJohn @MichvdHeijden Congrats to all! So many of my favorite people in this picture 🤩

[Professor Georgina Long AO (Bluesky @gvlongphdmd) @ProfGLongMIA]

Inspiring discussion re; #neoadjuvant #melanoma with colleagues from International Neoadjuvant Melanoma Consortium (INMC). Massive positive impact on patient outcomes. Areas to refine - how much surgery is needed, who needs what #immunotherapy & for how long, does #pathology response assessment need simplifying? Excited to report #NADINA results Sunday. @MelanomaAus @MDAndersonNews @NKI_nl

[Liz Burton, PhD @Liz_htx03]

Can’t imagine any other way to kick off #ASCO24! Incredible collaborations and multi disciplinary discussion today. Exciting things in melanoma and across cancers with neoadjuvant IO!

[Allison Betof, MD, PhD, FASCO @DrBetofMDPhD]

And we’re off!! @Liz_htx03 from @MDAndersonNews is kicking off #ASCO24 with the 2024 Neoadjuvant Melanoma Constorium meeting! What an exciting year for neoadjuvant melanoma therapy with the #NADINA trial being presented by @ProfCUBlankNKI as a Plenary Session! @OncoAlert

[Liz Burton, PhD @Liz_htx03]

@jennifercofer Congrats Dr. Cofer! So excited for you!

[OncoDaily @oncodaily]

3P Solutions - The first edition of the I.N.N.O.V.A.T.E - Neoadjuvant immunotherapy across cancers
@3PSolution @PAscierto @ProfCUBlankNKI @Liz_htx03
https://t.co/q89fdxkbXU

#Cancer #CancerResearch #HealthcareAdvancements #ImmunoTherapy #OncoDaily #Oncology

[Liz Burton, PhD @Liz_htx03]

@GlitzaMDPhD @MDAndersonNews @HTawbi_MD @JingLi_MD_PhD This pic makes my heart so happy! She is the BEST, amazing researcher and nurse!